Fingerprint
Dive into the research topics of 'Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2′-deoxycytidine (decitabine) in hematopoietic malignancies'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically